Integrated Research Limited Overview
Integrated Research is a 38-year-old Australian enterprise-software company whose single platform, Prognosis, provides real-time observability for three niche but mission-critical domains:
-
unified communications and contact-centre ecosystems ("Collaborate");
-
card, high-value and real-time payments environments ("Transact");
-
HPE NonStop fault-tolerant infrastructure ("Infrastructure").
Its customers are among the world's largest banks, card processors, telecommunications carriers and Fortune 500 enterprises. JPMorgan Chase, for example, has been a client for about 30 years. Revenue is dominated by multi-year term licences recognised upfront, so statutory results swing with the size of each year's renewal book.
After a decade of structural decline in its on-premise UC franchise, IR has pivoted under CEO Ian Lowe (since October 2024) to a "product-led growth" strategy. That strategy centres on AI-native products (the Iris assistant and IR Labs' Agentic SQA), observability-as-a-service (Prognosis Elevate) and utilisation-based pricing.
The company is debt-free and holds cash roughly equal to its market capitalisation. It is, however, shrinking: FY26 statutory revenue fell 16% to A$57.6m.
Company's own description (FY26 Annual Financial Report, paraphrased)
The FY26 Directors' Report describes IR's principal activities as designing, developing, implementing and selling software that monitors, in real time, the performance of business-critical computing, including UC networks and payment networks.
Prognosis is described as an integrated monitoring and management suite. It gives management and technical staff operational insight into, and helps them optimise:
-
HP NonStop systems;
-
distributed servers;
-
UC and payment environments;
-
the business applications running on those platforms.
The product is built on a fault-tolerant, highly distributed architecture designed for functionality and scalability.
IR reports serving clients in more than 40 countries. It sells through direct sales operations in the USA, UK, Germany, Singapore and Australia, plus a global channel network. Its customer base includes banks, credit-card companies, telecommunications carriers, technology companies, service providers and manufacturers.
The company's current tagline (FY26 market announcements) describes IR as a leading global provider of observability for business-critical IT ecosystems, powered by Prognosis across multi-vendor infrastructure, UC&CX and payments.
Business model and revenue model
| Revenue stream | Recognition | FY2026 (AUD Mn) | % of FY26 revenue (computed) |
|---|---|---|---|
| Licence fees (term licences, 1–5 years) | Point in time, on delivery of licence key | 38.8 | 67.3 |
| Maintenance fees | Ratably over the support term (1–5 years) | 11.6 | 20.2 |
| Subscription (SaaS / hosted) fees | Ratably over the term | 1.8 | 3.2 |
| Testing solution services | Over the service period | 2.1 | 3.6 |
| Professional services | As rendered / milestones | 3.3 | 5.7 |
| Total | — | 57.6 | 100.0 |
IR generates revenue from five statutory streams (FY26 Annual Financial Report, Note 3):
The model has five characteristic features.
-
Product vs. service vs. subscription vs. licensing mix.
-
IR is economically a recurring-revenue business: 92% of FY26 pro forma revenue was secured through term-based contracts (FY26 Investor Presentation).
-
However, it is accounted for as predominantly a licence business. About two-thirds of statutory revenue is term-licence fees recognised upfront.
-
Pure SaaS/subscription revenue is small (A$1.8m in FY26, down 54% year on year).
-
-
Pro forma revenue.
-
Management's preferred measure restates term licences on a straight-line, over-time basis.
-
FY26 pro forma revenue was A$65.8m, against statutory revenue of A$57.6m.
-
-
Total Contract Value (TCV).
-
TCV is bookings net of residual value from prior related contracts. It was A$54.3m in FY26, made up of:
-
renewals: A$38.5m
-
new business: A$10.9m
-
services: A$4.9m
-
-
-
Extended payment terms.
-
IR commonly grants customers multi-year payment terms (1–5 years).
-
It discounts the transaction price, recognising a financing component as finance income.
-
This is why receivables (A$58.2m at 30 Jun 2026, including A$22.3m non-current) are very large relative to revenue.
-
-
New utilisation-based (usage) models.
- Introduced in FY26 for the new AI products, under which clients pay by consumption rather than upfront commitment (FY26 Investor Presentation).
Value-chain position
IR is an independent software vendor (ISV) in the IT operations / observability layer. It sits above the underlying platforms:
-
HPE NonStop servers;
-
payment switches such as ACI's payment software;
-
UC/contact-centre platforms from vendors such as Microsoft, Cisco and Avaya.
It monitors and correlates their telemetry. IR does not own the platforms it monitors, so its value depends on platform-vendor ecosystems and on the gap between native vendor tooling and enterprise multi-vendor needs.
Customer types and end-markets
Per the FY26 Investor Presentation, IR's clients are concentrated in:
-
technology and telecommunications (leading telcos);
-
banking, financial services and insurance (leading US banks);
-
health, government and education;
-
retail and industrial (Fortune 500 companies and large enterprises).
New-client wins in FY26 included large US Government agencies and clients in health and finance.
Independent characterisation
IR is best understood as a mature, cash-generative niche-monitoring franchise with three distinct sub-businesses:
Infrastructure (HPE NonStop): a highly cash-generative but mature, ex-growth installed base. Management said exactly this in the FY24 Annual Report.
Transact (payments): a small but strategically valuable franchise among top-tier banks and processors. It was the only product line to grow statutory revenue in FY26 (+18%), driven by early renewals.
Collaborate (UC&CX): the historical growth engine, now in structural decline as enterprises migrate from on-premise UC to SaaS platforms with native monitoring. Collaborate's constant-currency net revenue retention was 83% in both FY25 and FY26.
The product-led growth (PLG) pivot is effectively an attempt to build a second-generation, AI-enabled and usage-priced product set on top of the trusted data position Prognosis holds inside client environments, before the legacy base erodes further.
Strategy
Stated corporate strategy (themes from FY25–FY26 filings, paraphrased)
The product-led growth (PLG) strategy was announced in August 2024 and reaffirmed in the FY26 Annual Financial Report. Its five elements are:
-
Invest in new products to restore sustainable revenue growth over the medium to long term. Management acknowledges IR has a mature product in a competitive global market.
-
Embed AI three ways:
-
as an innovation driver inside existing products (Iris);
-
as stand-alone, AI-native products (IR Labs / Agentic SQA);
-
as an internal productivity tool.
-
-
Lower adoption friction:
-
deployment friction (easier-to-adopt products);
-
pricing friction (usage-based SaaS with no upfront commitment);
-
contract friction (folding new products into existing client contracts).
-
-
Retain and expand the core:
-
retention features for NonStop clients;
-
expansion of Transact beyond cards into high-value and real-time payments;
-
Collaborate support for clients' cloud migration (FY24 Annual Report).
-
-
FY27 focus: improve the velocity of innovation and commercialisation, expand client engagement, minimise churn, and grow new-client, expansion and SaaS revenue (FY26 Investor Presentation).
The remuneration framework restates the strategy as maximising cash from the existing Collaborate, Transact and Infrastructure lines and reinvesting capital in new product lines (FY26 Remuneration Report).
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Date | Description | Status |
|---|---|---|---|
| IR Labs innovation incubator | Launched Aug 2024 | Small cross-functional squads building stand-alone AI products | Active; flagship Agentic SQA in beta/MVP |
| Testing solutions divestment | Dec 2024 | Non-core testing products sold to Voxology to focus resources | Completed; A$1.2m gain in FY25 |
| HVP product | First client Apr 2025 | Expands Transact into Fedwire/SWIFT/CHIPS flows | Implementation complete with a top-10 US bank; other global banks engaged |
| IR Hosted Prognosis → Prognosis Elevate | First sale FY25; launched 4 Nov 2025 | Observability-as-a-service for UC&C | Live |
| Iris AI interface | 2 Dec 2025 | Natural-language AI layer in Prognosis | First clients activated |
| Iris for Card Payments | Beta from May 2026 (Prognosis 13.3) | Domain-specific AI assistant for card payments | Beta, free with usage limits; extensions to HVP and real-time payments planned |
| Agentic SQA | Beta/MVP in FY26 | Stand-alone agentic AI software-quality product | First clients activated |
| Utilisation-based pricing | FY26 | Usage-based SaaS model for AI products | Introduced |
| Product and technology investment uplift | FY26 | Spend +29% to A$17.4m (30% of revenue), with no capitalisation | Continuing into FY27 |
| Cost reallocation | FY26 | Sales and marketing −10%; G&A ex-credit losses reduced | Achieved |
| Capital allocation framework | Published 27 Aug 2026 | See 10.4 | Active |
Sustainability and ESG commitments
These are limited:
-
an ESG Steering Committee (formed FY23);
-
sustainable office selection and recycling;
-
preparation for mandatory climate reporting (Group 3, for financial years starting on or after 1 Jul 2027).
Capital allocation framework, FY27 (FY26 Investor Presentation)
| Bucket | Medium-term allocation of available capital | Purpose |
|---|---|---|
| Innovation investment | 30–35% | Product innovation across Prognosis and IR Labs |
| Flexibility reserves | 20–35% | Opportunistic deals, e.g., right-sized, synergistic M&A in growth markets |
| Contingency reserves | 30–35% | Working capital and operating cash needs |
| Shareholder returns | Dividend policy: at least 25% of free cash flow (Board discretion) | FY26: 3.0c ordinary plus 2.0c special |
Management guidance and medium-term targets
No numerical FY27 revenue or EBITDA guidance has been issued: - Management states that investment in PLG will weigh on profit over the short to medium term, and that the FY27 renewals book is weighted to the second half.
Implicit target: the FY26 LTI requires underlying basic EPS CAGR of at least 10% from 6.84c (FY25 base) to FY28. Full vesting therefore implies FY28 UBEPS of about 9.1c, against FY26 basic EPS of 0.67c.
Historical framework (FY24 AGM): allocate up to an additional 10% of TCV a year to product innovation for new revenue. This was superseded by the FY27 capital allocation framework.
Products & Services
All products are delivered on, or alongside, the Prognosis platform.
Current version: 13.x. Version 13.3 was released in about May 2026, per the IR Transact 13.3 release notes and the June 2026 PR.
Pricing: list prices are not publicly disclosed. Contracts are typically term licences of one to five years (average 3.2 years in FY26) with attached maintenance. New AI products use utilisation (usage-based) pricing.
Prognosis platform (core)
| Attribute | Detail |
|---|---|
| Description | Real-time monitoring, analytics and management platform for multi-vendor, business-critical environments |
| Architecture | Fault-tolerant, highly distributed; deployable on-premise, hybrid, or IR-hosted (Elevate) |
| Scale claim | Monitors more than 80 billion payment transactions a year for large banks and financial institutions (IR / PR Newswire, Jun 2026) |
| Target customer | Large enterprises in banking/payments, telecoms, government, health and Fortune 500 companies |
| Latest version | Prognosis 13.3 (2026) |
IR Collaborate (UC&C and contact-centre observability)
| Offering | Description | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Collaborate (Prognosis for UC&C) | Performance management, analytics and troubleshooting across voice, video, web and collaboration ecosystems; on-premise, cloud or hybrid; multi-vendor | Large enterprises with complex UC/contact-centre estates | Long-standing; continuously released | Term licence plus maintenance; some SaaS |
| Collaborate cloud/SaaS | Cloud-delivered Collaborate monitoring; Collaborate SaaS revenue was A$1.8m in FY26 (+6%) | Enterprises migrating to UCaaS/CCaaS | FY21–22 onwards (Prognosis Cloud) | Subscription |
| Collaborate Space Management | Analytics on meeting-room/space utilisation | Enterprise facilities and IT teams | Launched FY22 | — |
| Prognosis Elevate | Fully managed observability-as-a-service for UC&C. IR hosts and operates Prognosis for the client. First new business secured in FY25 as "IR Hosted Prognosis". | Clients seeking to avoid self-hosted infrastructure | Launched 4 Nov 2025 | Subscription / as-a-service |
| Testing solutions (HeartBeat, WebBeat, StressTest) | Voice/web experience and load testing for contact centres | Contact-centre operators | Divested to Voxology Dec 2024; IR retains resale rights; testing revenue of A$2.1m in FY26 | Service fees |
IR Transact (payments observability)
| Offering | Description | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Transact for Card Payments | End-to-end monitoring of card-payment switching and authorisation flows; analyses transaction data to protect payment experience | Card issuers, acquirers, processors, top-tier banks | Long-standing; v13.3 (2026) | Term licence plus maintenance |
| High Value Payments (HVP) | Real-time visibility and control of high-value payment flows (e.g., Fedwire, SWIFT, CHIPS); v13.3 adds ACI MTS TSI integration | Global systemically important banks | First client deployed (top-10 bank), announced 24 Apr 2025; implementation completed FY26 | Term licence (details not disclosed) |
| Real-Time Payments monitoring | Observability of instant-payment rails; Iris extension planned | Banks adopting real-time rails | Roadmap (planned Iris extension) | — |
| Iris for Card Payments | Natural-language AI assistant purpose-built for card-payments observability; built-in IR correlation logic explains why an issue occurred | Payments operations teams | Beta from May 2026 in Prognosis 13.3; free in beta (usage limits may apply) | Utilisation-based intended; currently no charge in beta |
IR Infrastructure (HPE NonStop)
| Offering | Description | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|
| Prognosis for HPE NonStop | Real-time performance insight, pattern detection and proactive problem prevention for HPE NonStop environments | Banks, exchanges, telcos and processors running NonStop | IR's original franchise (since 1988); current v13.x | Term licence plus maintenance |
AI and new-product portfolio (product-led growth)
| Offering | Description | Status | Revenue model |
|---|---|---|---|
| Iris (platform AI interface) | Conversational / natural-language AI interface integrated into Prognosis for deeper discovery; foundation for further AI offerings | Launched 2 Dec 2025; first clients activated (FY26) | Utilisation-based (SaaS) |
| Agentic SQA (IR Labs) | IR's first stand-alone agentic AI product. It automates software quality assurance by turning static-analysis, fuzzer, sanitiser and CI signals into triaged, validated, developer-ready outputs. IR positions it as an evidence-first, reviewable system rather than a one-click autonomous fixer (per IR Labs job description). | Beta and MVP released in FY26; first clients activated | Utilisation-based (SaaS) |
| AI-driven analytics | AI/ML analytics extracting additional value from data already collected by Prognosis | Introduced/expanded in FY26 | Bundled / utilisation |
Professional services
Implementation, configuration and consulting services for licensed software. Revenue was A$3.3m in FY26, down 13% (FY26 Annual Financial Report).
Portfolio assessment
The portfolio is narrow and deep. Its moat lies in decades of domain-specific instrumentation (NonStop internals, payment-switch message flows, multi-vendor UC signalling) that general-purpose observability platforms do not replicate out of the box.
The weakness is that each legacy domain is either shrinking (on-premise UC) or mature (NonStop). The new AI products are, by management's own admission, at an early stage and not yet generating meaningful revenue (FY26 Directors' Report).
Financial Narrative
Basis: statutory A$ figures from the Annual Financial Reports and results releases for FY22–FY26, unless marked computed. IR does not report cost of sales or gross profit. Its expenses are presented by function (product & technology; sales, professional services & marketing; general & administration).
Income statement
Notes:
-
FY22 tax is computed as NPAT less PBT.
-
FY23 pro forma EBITDA is A$17.527m per the FY24 Annual Report reconciliation. The FY24 three-year index table shows A$17.575m, a minor discrepancy in the company's own documents.
-
FY22 statutory EBITDA, operating expense and D&A were not available in the reviewed FY22 extracts.
Margins and growth (computed)
Revenue CAGR (computed):
-
Statutory revenue FY2022–FY2026: about −2.2% a year (A$62.9m to A$57.6m).
-
Pro forma revenue FY2022–FY2026: about −4.7% a year (A$79.8m to A$65.8m).
-
Statutory revenue CAGR from the FY2020 peak (A$110.9m) to FY2026: about −10.3% a year.
Half-yearly progression: notes and sources
Source: H1 FY25 and H1 FY26 Interim Results. H2 figures are computed as full year less H1.
Balance sheet: notes and sources
Note: FY22 equity is the opening FY23 balance per the FY24 Annual Report statement of changes in equity. Goodwill and intangibles were fully written off in FY23. No R&D has been capitalised since FY24.
Cash flow: notes and sources
Note: FY22 net cash flow before financing activities (A$7.191m) is from the FY24 Remuneration Report index table. FY25 proceeds from the sale of the testing business were A$0.76m.
Ratios (computed unless noted)
Notes:
-
Net debt/EBITDA is not meaningful: IR has net cash in every year and negative EBITDA in FY26.
-
Invested capital = equity + lease liabilities − cash.
-
The cash conversion cycle approximates receivables days, because IR holds no inventory and has modest payables. It is structurally distorted by multi-year customer payment terms.
Commentary on trends, inflections and drivers
Revenue.
-
IR's statutory revenue has followed a renewal-cycle sawtooth around a declining trend: A$110.9m in FY20, A$78.5m in FY21, A$62.9m in FY22, A$69.8m in FY23, A$83.3m in FY24, A$68.3m in FY25 and A$57.6m in FY26.
-
The FY24 spike was a strong renewal year (large multi-year Infrastructure and Transact renewals plus the Fiserv deal), not structural growth. Pro forma revenue actually fell 1% that year.
-
The FY26 decline combined three things:
-
a soft renewals book (renewal TCV −21% to A$38.5m);
-
weaker second-half new business, with deferrals into FY27 amid protracted US procurement and compliance cycles;
-
shorter contract terms on new wins, attributed partly to client caution about AI-driven change (FY26 Directors' Report).
-
Profitability.
-
FY24 marked the cost-reset peak. Product and technology spend was cut 46% and headcount fell to 142, producing a 29.5% EBITDA margin.
-
FY25 kept costs down (expenses −5%) but revenue fell, and the effective tax rate normalised to 27.5% after R&D credits were used up.
-
FY26 swung to an EBITDA loss of A$2.1m from:
-
lower revenue;
-
a A$5.0m expected credit loss charge, of which A$3.8m related to a single client and was unrelated to software performance;
-
A$2.7m of FX losses;
-
a deliberate 29% increase in product and technology spend to A$17.4m (30% of revenue).
-
-
Excluding the credit loss, operating expenses were broadly flat at A$53.1m.
-
Positives: second-half EBITDA was positive (about A$1.0m, computed), and pro forma EBITDA remained positive at A$8.7m.
Balance sheet.
-
The balance sheet is very liquid: A$51.7m cash, no borrowings, current ratio 4.5x.
-
The largest asset is A$58.2m of trade receivables, reflecting extended payment terms granted on multi-year licence deals.
-
Receivables fell 21% in FY26 as collections exceeded new billings. This supported operating cash flow of A$12.6m despite near-zero profit.
-
The A$3.8m single-client provision shows that these long-dated receivables carry real credit risk.
Cash flow.
-
Cash generation has been consistent: A$13.0m (FY24), A$8.7m (FY25) and A$12.6m (FY26) of operating cash flow.
-
FY25 was depressed by A$4.4m of tax payments; FY26 benefited from a tax refund.
-
Interest income (A$3.6m in FY26) is now a meaningful earnings contributor.
-
The company has never bought back shares in the period reviewed.
Capital returns.
-
Dividends resumed in FY24 (2.0c) after a period of no dividends in FY22–FY23.
-
FY26 brought a 3.0c ordinary dividend plus a 2.0c special, about A$9.0m in total. That equals roughly 7.5x FY26 NPAT and about 73% of FY26 free cash flow, signalling the Board's view that cash exceeds investment needs.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue statutory (AUD Mn) | 62.9 | 69.8 | 83.3 | 68.3 | 57.6 |
Revenue growth statutory (%) | -19.9 | 11.1 | 19.3 | -18.1 | -15.6 |
Pro forma revenue (AUD Mn) | 79.8 | 75.6 | 74.8 | 74.3 | 65.8 |
Total contract value TCV (AUD Mn) | 56.7 | 68.5 | 83.9 | 67.3 | 54.3 |
Total operating expenses incl impairment (AUD Mn) | — | 102.7 | 58.0 | 54.9 | 58.8 |
Impairment expense (AUD Mn) | — | 31.8 | 0.0 | 0.0 | 0.0 |
Other gains or losses (AUD Mn) | — | 1.4 | -0.9 | 2.1 | -1.6 |
Operating income EBIT before finance income (AUD Mn) | — | -31.5 | 24.5 | 15.5 | -2.8 |
EBITDA statutory (AUD Mn) | — | -19.7 | 24.6 | 15.9 | -2.1 |
EBITDA excluding impairment (AUD Mn) | — | 12.1 | 24.6 | 15.9 | -2.1 |
Pro forma EBITDA (AUD Mn) | 24.5 | 17.5 | 16.7 | 21.5 | 8.7 |
Depreciation and amortisation (AUD Mn) | — | 11.8 | 0.1 | 0.4 | 0.7 |
Finance income (AUD Mn) | — | 2.2 | 2.2 | 3.0 | 3.6 |
Pre-tax income (AUD Mn) | -2.4 | -29.3 | 26.7 | 18.4 | 0.7 |
Income tax expense (benefit negative) (AUD Mn) | -4.0 | -0.1 | -0.4 | 5.1 | -0.5 |
Net income NPAT (AUD Mn) | 1.5 | -29.2 | 27.1 | 13.4 | 1.2 |
NPAT excluding impairment (AUD Mn) | 1.5 | 2.6 | 27.1 | 13.4 | 1.2 |
EPS basic (A cents) | 0.90 | -16.90 | 15.57 | 7.56 | 0.67 |
EPS diluted (A cents) | — | -16.90 | 15.18 | 7.43 | 0.67 |
Dividends declared per share total (A cents) | 0.00 | 0.00 | 2.00 | 2.00 | 5.00 |
of which special dividend per share (A cents) | 0.00 | 0.00 | 0.00 | 0.00 | 2.00 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin statutory (%) | — | -28.2 | 29.5 | 23.3 | -3.7 |
EBITDA margin excluding impairment (%) | — | 17.3 | 29.5 | 23.3 | -3.7 |
Operating EBIT margin (%) | — | -45.1 | 29.4 | 22.7 | -4.9 |
Net margin (%) | 2.4 | -41.9 | 32.6 | 19.6 | 2.1 |
Pro forma EBITDA margin on pro forma revenue (%) | 30.7 | 23.1 | 22.3 | 28.9 | 13.2 |
Effective tax rate (%) | — | — | -1.6 | 27.5 | -64.4 |
Income Statement
| Metric | H1FY2025 | H2FY2025 | H1FY2026 | H2FY2026 |
|---|---|---|---|---|
Revenue statutory (AUD Mn) | 28.8 | 39.5 | 28.3 | 29.3 |
Pro forma revenue (AUD Mn) | 36.6 | 37.7 | 34.4 | 31.4 |
EBITDA statutory (AUD Mn) | 4.6 | 11.3 | -3.1 | 1.0 |
NPAT (AUD Mn) | 4.6 | 8.8 | -1.5 | 2.7 |
Cash at period end (AUD Mn) | — | 40.6 | 43.6 | 51.7 |
Expense line (AUD Mn)
| Expense line (AUD Mn) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Product and technology expense net (AUD Mn) | 23.7 | 12.8 | 13.5 | 17.4 |
Sales professional services and marketing (AUD Mn) | 40.9 | 38.7 | 34.1 | 30.8 |
General and administration (AUD Mn) | 6.3 | 6.5 | 7.3 | 10.6 |
Expected credit loss expense within G and A (AUD Mn) | — | — | 0.1 | 5.0 |
Impairment (AUD Mn) | 31.8 | 0.0 | 0.0 | 0.0 |
Total expenditure (AUD Mn) | 102.7 | 58.0 | 54.9 | 58.8 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | — | 89.7 | 114.2 | 123.0 | 119.4 |
Cash and equivalents (AUD Mn) | 12.3 | 18.6 | 31.9 | 40.6 | 51.7 |
Borrowings short term (AUD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Borrowings long term (AUD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Lease liabilities current (AUD Mn) | — | 1.6 | 1.3 | 0.7 | 0.5 |
Lease liabilities non-current (AUD Mn) | — | 1.5 | 0.4 | 1.1 | 1.0 |
Net debt (negative = net cash, excl leases) (AUD Mn) | -12.3 | -18.6 | -31.9 | -40.6 | -51.7 |
Total equity (AUD Mn) | 87.1 | 59.9 | 88.4 | 100.6 | 98.0 |
Goodwill and intangibles (AUD Mn) | — | 0.0 | 0.0 | 0.0 | 0.0 |
Trade receivables current (AUD Mn) | — | 40.9 | 41.6 | 40.8 | 35.9 |
Trade receivables non-current (AUD Mn) | — | 22.5 | 31.9 | 33.0 | 22.3 |
Deferred revenue (AUD Mn) | — | 14.1 | 13.9 | 11.5 | 10.6 |
Current assets (AUD Mn) | — | 63.1 | 77.9 | 84.9 | 91.1 |
Current liabilities (AUD Mn) | — | 27.2 | 24.9 | 20.8 | 20.1 |
Working capital (AUD Mn) | — | 35.8 | 53.0 | 64.0 | 71.1 |
Net tangible assets per share (A cents) | — | — | — | 56.73 | 54.28 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash receipts from customers (AUD Mn) | — | 76.3 | 72.4 | 66.7 | 64.7 |
Operating cash flow (AUD Mn) | — | 13.8 | 13.0 | 8.7 | 12.6 |
Income taxes paid (refunded negative) (AUD Mn) | — | 1.7 | 1.0 | 4.4 | -0.1 |
Capex property plant and equipment (AUD Mn) | — | 0.3 | 0.0 | 0.5 | 0.3 |
Capitalised development (AUD Mn) | — | 7.5 | 0.0 | 0.0 | 0.0 |
Free cash flow OCF less capex and capitalised dev (AUD Mn) | — | 6.0 | 13.0 | 8.2 | 12.4 |
Lease principal payments (AUD Mn) | — | 1.6 | 1.6 | 1.4 | 0.7 |
Interest received (AUD Mn) | — | 2.2 | 2.3 | 2.9 | 3.6 |
Dividends paid (AUD Mn) | 0.0 | 0.0 | 0.0 | 3.5 | 3.5 |
Share buybacks (AUD Mn) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net cash flow before financing (AUD Mn) | 7.2 | 7.2 | 15.3 | 12.8 | 16.0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE company reported (%) | 2 | -40 | 37 | 14 | 1 |
ROA on average total assets (%) | — | — | 26.6 | 11.3 | 1.0 |
ROIC NOPAT at 30pct notional tax on end capital (%) | — | -49.7 | 29.4 | 17.5 | -4.1 |
Current ratio (x) | — | 2.32 | 3.13 | 4.07 | 4.54 |
Debt to equity borrowings only (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Lease-adjusted debt to equity (x) | — | 0.05 | 0.02 | 0.02 | 0.02 |
EBITDA to interest paid (x) | — | — | 256 | 157 | -22 |
Asset turnover (x) | — | — | 0.82 | 0.58 | 0.48 |
Receivables days total receivables over revenue (days) | — | 332 | 322 | 394 | 369 |
Cash conversion OCF over EBITDA (%) | — | 114 | 53 | 55 | — |
Revenue by Region
| Region (local currency) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Americas revenue (USD Mn) | 28.1 | 39.1 | 30.9 | 28.1 |
Asia Pacific revenue (AUD Mn) | 17.2 | 15.8 | 15.5 | 11.0 |
Europe revenue (GBP Mn) | 5.8 | 4.1 | 2.4 | 2.7 |
Region growth (%)
| Region growth (%) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Americas growth in US$ (%) | 39 | -21 | -9 |
Asia Pacific growth in A$ (%) | -8 | -2 | -29 |
Europe growth in GBP (%) | -28 | -43 | 13 |
Revenue by Region (FY2025–FY2026)
| Region (AUD Mn) | FY2025 | FY2026 |
|---|---|---|
Americas revenue (AUD Mn) | 48.1 | 41.3 |
Asia Pacific revenue (AUD Mn) | 15.5 | 11.0 |
Europe revenue (AUD Mn) | 4.7 | 5.3 |
Geographic Revenue
| Territory | FY2026 pro forma (AUD Mn) | Change vs FY2025 |
|---|---|---|
Americas | 45.0 | −13% |
APAC | 13.8 | −7% |
Europe | 7.0 | −11% |
Share Price and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Closing share price at 30 June (AUD) | 0.42 | 0.39 | 0.93 | 0.42 | 0.27 |
Annual share price change (%) | — | -7.1 | 138.5 | -54.8 | -35.7 |
Period (to 30 Jun 2026 unless noted) | Price return | Basis | — | — | — |
1 year | −35.7% | A$0.42 to A$0.27 | — | — | — |
3 years | −30.8% | A$0.39 to A$0.27 | — | — | — |
4 years | −35.7% | A$0.42 to A$0.27 | — | — | — |
5 years | — | FY21 closing price not confirmed in reviewed sources; the stock traded as high as about A$2.13 within FY21 | — | — | — |
Latest verified price | A$0.295 (21 Aug 2026) | InvestSMART | — | — | — |
52-week range (as of Mar 2026) | A$0.27 – A$0.51 | Market data (Halo) | — | — | — |
Valuation Multiples
| Multiple | IR value | Comment |
|---|---|---|
Market capitalisation | About A$53.3m | Cum-dividend |
Enterprise value (market cap − cash + leases) | About A$3.1m | About A$12.1m after the A$9.0m October 2026 dividend outflow, holding price constant |
P/E (FY26 basic EPS 0.67c) | About 44x | Depressed earnings |
P/E (FY25 basic EPS 7.56c) | About 3.9x | — |
EV/Pro forma EBITDA (A$8.7m) | About 0.4x | Pre-dividend EV |
EV/Sales (FY26 statutory) | About 0.05x | About 0.2x post-dividend |
P/B (book A$98.0m) | About 0.54x | Book is almost entirely cash and receivables |
Dividend yield (5.0c incl special) | About 16.9% | 10.2% on the 3.0c ordinary dividend alone |
Per-Share Data and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Ordinary dividend declared per share (A cents) | 0.0 | 0.0 | 2.0 | 2.0 | 3.0 |
Special dividend declared per share (A cents) | 0.0 | 0.0 | 0.0 | 0.0 | 2.0 |
Franking (%) | — | — | 100 | 100 | 100 |
Dividends paid in cash during year (AUD Mn) | 0.0 | 0.0 | 0.0 | 3.5 | 3.5 |
Analyst Conclusions
Management guidance
No quantitative FY27 guidance has been issued: - Qualitative guidance (FY26 Results, 27 Aug 2026):
-
continued investment in new products, with PLG weighing on profit over the short to medium term;
-
the FY27 renewals book is weighted to the second half;
-
focus on commercialising new products, minimising churn, and growing new-client, expansion and SaaS revenue.
Capital allocation: 30–35% of available capital to innovation; 20–35% flexibility reserves (including M&A); 30–35% contingency; dividends of at least 25% of free cash flow.
Consensus growth expectations
Not publicly verifiable. Coverage is limited and historic consensus (FNArena) appears stale.
Bull case
-
The balance sheet caps downside. Net cash of about A$43m after the Oct 2026 dividend is close to the market capitalisation. Investors are paying little for a business that still generated A$12.6m of operating cash flow and A$8.7m of pro forma EBITDA in a trough year.
-
Payments is a real growth vector. Transact grew statutory revenue 18% in FY26. HVP is live at a top-10 bank with other global banks engaged. Iris for Card Payments brings AI into a domain where IR monitors more than 80 billion transactions a year. Each additional tier-one HVP client would be material relative to A$10.9m of annual new-business TCV.
-
A second-half-weighted FY27 renewal book plus new AI products could produce a statutory rebound similar to FY24, when revenue rose 19% and NPAT reached A$27.1m. The cost base is controlled (expenses ex-credit losses broadly flat at A$53.1m), giving high operating leverage to renewal timing.
Bear case
-
The core is in structural decline. Pro forma revenue has fallen from A$79.8m (FY22) to A$65.8m (FY26), and the decline accelerated to −12% in FY26. Collaborate NRR is stuck at 83%, and down-sell has now spread to Transact and Infrastructure.
-
New products may not scale. Subscription revenue fell 54% in FY26. New-client TCV hit only 29% of target. A 30%-of-revenue R&D budget is minuscule against AI-heavy platforms (Datadog's R&D is 45% of a US$3.4bn base). IR may be outspent in exactly the AI features it is betting on.
-
Earnings quality and credit risk. About 67% of revenue is upfront licence recognition with multi-year payment terms. That leaves A$58.2m of receivables (about 369 days of revenue), and FY26 already produced a A$3.8m single-client loss. Further provisions, or slower collections as contract terms shorten, would erode the cash story that underpins the valuation.
Key catalysts and monitorables (next 12 months)
| Item | Expected timing | What to watch |
|---|---|---|
| FY26 Annual Report (top-20 holders) | About 16 Oct 2026 | Identity of the Jul 2026 substantial holder change; founder stake |
| 2026 AGM | About Nov 2026 (date not confirmed) | Remuneration vote; any FY27 commentary; Board renewal (Hitz and Brayan's terms were due by the 2026 AGM per the FY24 report) |
| H1 FY27 trading update | About Nov–Dec 2026 (based on prior pattern) | New-business TCV vs FY26; AI product utilisation metrics |
| H1 FY27 results | About Feb 2027 | Subscription/SaaS revenue trajectory; credit-loss recoveries |
| HVP second client | Any time | Conversion of engaged global banks |
| Iris general availability and monetisation | FY27 | Move from free beta to paid utilisation; HVP/real-time payments extensions (Prognosis 13.4) |
| Agentic SQA commercial launch | FY27 | Paying customers; pricing |
| M&A from flexibility reserve | Opportunistic | Deal size and fit versus the "right-sized, synergistic" criterion |
| H2 FY27 renewals | Jan–Jun 2027 | Size and term of renewal cohort; down-sell |
| Mandatory climate reporting preparation | FY27 | Disclosure readiness for FY28 |
Concluding analyst verdict
Integrated Research is a classic "cash shell with a declining annuity and an option attached."
The annuity is a 38-year-old observability franchise with genuine domain depth in NonStop, payments and multi-vendor UC. It still converts revenue into cash reliably: A$12.6m of operating cash flow in FY26 despite an EBITDA loss. It carries no debt and has no goodwill to impair. That annuity is shrinking, though, and the decline is no longer confined to Collaborate. In FY26 pro forma revenue fell 12%, renewal TCV fell 21%, new-business TCV fell 21%, and management reports down-sell across Transact and Infrastructure in the Americas.
The option is the PLG and AI portfolio: Iris, Iris for Card Payments, HVP, Prognosis Elevate and IR Labs' Agentic SQA. The direction is strategically sensible. IR's trusted, deep-in-the-stack data access in regulated institutions is a credible foundation for domain-specific AI assistants. Execution evidence, however, is thin. Products are in beta or at first-client stage, subscription revenue halved, and the executive scorecard shows new-client TCV at 29% of target.
The market is pricing the company at roughly net cash: enterprise value of about A$3–12m depending on dividend timing, and about 0.5x book. That valuation implicitly assumes the operating business is worth close to nothing, which looks too punitive while it still produces A$8–13m of annual operating cash flow. Yet value realisation depends on one of three things:
-
stabilising pro forma revenue;
-
demonstrable AI monetisation;
-
capital returns or a control transaction, in which the founder's 28.9% stake is pivotal.
Verdict: a deep-value, high-uncertainty special situation rather than a growth investment. Downside is cushioned by cash and the dividend policy. Upside requires visible evidence in H1 FY27 that new-business TCV and utilisation revenue are inflecting. The most important near-term data points are the H1 FY27 trading update, any second HVP win, and the conversion of Iris from free beta to paid usage. Without those, the likeliest path is continued managed decline funded by, and gradually consuming, the cash pile.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Prior roles | Education |
|---|---|---|---|---|
Ian Lowe | CEO (from 1 Oct 2024) and Managing Director (Board from Oct 2024) | About 2 years | CEO, Wealth99; CEO, EP&T Global; CEO and Executive Director, Adslot (ASX); about 25 years of technology leadership in big-data software for media, finance and sustainability | — |
Christian Shaw | Chief Financial Officer (joined Jan 2024; CFO from 1 Mar 2024); also responsible for People & Culture and Legal | About 2.5 years | CFO roles at AJG Australia, Multicom Resources, Unith Limited, Moko Social Media, iCash Payment Systems | B.Bus (UTS); CPA |
Leanne Ralph | Company Secretary (Nov 2024) | About 2 years | Founder, Boardworx Australia; outsourced company secretary to Appen, ImpediMed, SenSen Networks and others; NED of Dicker Data (ASX) | B.Bus (UTS); FGIA; GAICD |
“—” = not publicly disclosed.
Board of Directors
| Director | Role | Appointed | Independence | Committees | Background |
|---|---|---|---|---|---|
Peter Lloyd (MAICD) | Chair | Director Jul 2010; Chair Mar 2021 | Independent NED (tenure over 16 years) | Board Chair; member of ARC, PRNC, TIC | 45+ years in computing; 35 years in payments solutions for banks; proprietor of The Grayrock Group; NED of Taggle Pty Ltd |
Ian Lowe | CEO and MD | Oct 2024 | Executive | — | As above |
Michael Hitz (BE Hons) | NED | Oct 2023 | Independent | Chair, Technology & Innovation Committee; member, ARC | Former Partner and MD, Boston Consulting Group (TMT); investor with a pan-Asian fund; Director, Institute for Economics and Peace |
Mark Brayan (BSurv Hons, MBA AGSM) | NED | Nov 2023 | Independent | Chair, People, Remuneration & Nomination Committee; member, TIC | Former CEO/MD of Appen (ASX), Soprano Design, MineSite Technologies and of IR itself; Chair of SenSen Networks (ASX) and Shorthand |
Kate Greenhill (BEc, FCA, GAICD) | NED | Apr 2024 | Independent | Chair, Audit & Risk Committee; member, PRNC | Former PwC Partner (Australia and UK); Director of Total Risk Management and Intersect Australia; ex-Director of Australian Ethical Investment |
Directors' Remuneration
| Person | Salary/fees | STI/bonus | Superannuation | Long service leave | Share-based (LTI) | Total |
|---|---|---|---|---|---|---|
Ian Lowe (CEO & MD) | 535,600 | 105,000 | 30,000 | 8,926 | 73,632 | 753,158 |
Christian Shaw (CFO) | 387,000 | 85,000 | 30,000 | 6,449 | 49,539 | 557,988 |
Peter Lloyd (Chair) | 165,536 | — | 19,864 | — | — | 185,400 |
Mark Brayan | 91,964 | — | 11,036 | — | — | 103,000 |
Kate Greenhill | 91,964 | — | 11,036 | — | — | 103,000 |
Michael Hitz | 91,964 | — | 11,036 | — | — | 103,000 |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
Sep 2023 – Mar 2024 | Brackin, Myers, Scott and Aston retire; Hitz, Brayan and Greenhill appointed | Board renewal during the turnaround |
Feb–Mar 2024 | Interim CFO Matthew Walton departs; Christian Shaw becomes CFO | Finance leadership change |
16–17 Jul 2024 | John Ruthven steps down as MD; CEO transition announced | The Board sought a leader from outside IR's product areas to find new revenue sources |
1 Oct 2024 | Ian Lowe starts as CEO (later appointed MD) | Product-led growth mandate |
Oct–Nov 2024 | Will Witherow replaced as Company Secretary by Leanne Ralph | Outsourced company-secretarial model |
16 Jan 2025 | Ruthven's employment ends (after gardening leave) | Termination benefit of A$176,061 recognised in FY25 |
Major Shareholders
| Holder | Shares | % of issued capital | Date / source |
|---|---|---|---|
Stephen John Killelea (founder; holdings via associated entities) | 52,218,231 | 28.92% | Sep 2025 register data (MarketScreener); 29.71% (51.88m shares) per the 20 Sep 2023 substantial holder notice |
Unidentified holder | — | — | Form 604 change in substantial holding lodged 14 Jul 2026; holder identity not captured in reviewed sources |
Other top-10 holders | Not publicly disclosed in reviewed sources | — | Top-20 holder list expected in the FY26 Annual Report (scheduled about 16 Oct 2026) |
Institutional ownership (SEC 13F-type filers) | about 54,754 shares | about 0.03% | Fintel, Sep 2025 (Dimensional, Old Westbury); immaterial |
Directors' Shareholdings
| Director | Shares | Other interests |
|---|---|---|
Peter Lloyd | 51,263 | — |
Mark Brayan | 260,000 | — |
Michael Hitz | 300,000 | Bought on market in Dec 2025 at about A$0.31–0.35 |
Kate Greenhill | 90,000 | Bought Nov 2025 at about A$0.31 |
Ian Lowe | 0 | 984,621 performance rights |
Christian Shaw | 0 | 847,182 performance rights |
Competitive Landscape
Competitors by Segment
| Segment | Competitor | Type | Revenue (latest public) | Positioning vs IR |
|---|---|---|---|---|
Collaborate (UC&CX observability) | Nectar Services Corp. | Private specialist | — | Direct multi-vendor UC monitoring rival; strong in contact-centre and Teams/Zoom/Webex observability |
Collaborate | Vyopta | Private specialist | — | UC&C analytics and monitoring; competes for enterprise UC estates |
Collaborate | Martello Technologies (TSXV: MTLO) | Listed specialist | — | Microsoft 365/Teams digital-experience monitoring (Vantage DX) |
Collaborate | Unify Square (PowerSuite) | Private specialist | — | Teams/Zoom management and monitoring |
Collaborate | Microsoft (native Teams Call Quality Dashboard / admin tooling) | Platform vendor | n/a (segment not separable) | Native tooling narrows third-party value; this is IR's key structural threat in UC |
Collaborate | Cisco (ThousandEyes, Webex Control Hub) | Platform vendor | — | Native and network-path observability for Cisco estates |
Collaborate (testing, adjacent) | Cyara (incl. Spearline) | Private CX assurance | — | CX testing leader; competes with the divested testing products |
Transact (payments observability) | INETCO Systems | Private specialist | — | Closest direct payments-transaction monitoring rival |
Transact / cross-domain | Splunk (Cisco, acquired 2024) | Platform | n/a (inside Cisco) | General log analytics used for payments monitoring |
Cross-domain observability | Dynatrace (NYSE: DT) | Listed platform | US$2,018m, FY ended Mar 2026 (+19%) | AI-powered full-stack observability; a Gartner MQ Leader (2025) |
Cross-domain observability | Datadog (NASDAQ: DDOG) | Listed platform | About US$3.43bn, CY2025 (about +28%) | Cloud-native observability; rapid AI feature cadence |
Infrastructure (HPE NonStop) | HPE native NonStop performance tooling | Platform vendor | — | Built-in alternative; IR is the established third-party specialist |
“—” = not publicly disclosed.
Peer Comparison FY2025
| Metric | Integrated Research (FY ended Jun 2026) | Dynatrace (FY ended Mar 2026) | Datadog (CY2025) |
|---|---|---|---|
Revenue | A$57.6m (about US$37m) | US$2,018m | About US$3,430m |
Revenue growth | −16% statutory; −12% pro forma | +19% (+17% cc) | About +28% |
GAAP operating margin | −4.9% (EBIT before finance income) | About 12% (GAAP operating income US$245m; computed) | — |
Non-GAAP / adjusted margin | Pro forma EBITDA margin 13.2% | Non-GAAP operating margin about 29% (US$592m; computed) | Non-GAAP operating margin about 22% (FY25 guidance basis) |
R&D intensity | 30% of revenue | About 24% (computed from a US$89.7m, 23% increase) | 45% (FY2025 10-K) |
Balance sheet | Net cash A$51.7m; no debt | Net cash (buybacks of US$479m in FY26) | Net cash |
Recent Developments
FY26 headcount rose by 7 to 138.



